TrialNeuro-oncology2011

Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma.

Derek R Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.